CareDx, Stanford Add Third Patent to IP Lawsuit Against Natera

Mar 17, 2020

|

This story has been updated with a statement from Natera.

NEW YORK – CareDx and Stanford University have added a third patent to their patent infringement lawsuit against Natera, filing an amended complaint in the United States District Court for Delaware.

The plaintiffs now also claim that Natera has infringed on US Patent 10,329,607, which is exclusively licensed to CareDx from Stanford.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

NSF's Investigations

Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.

OK, So Who Is Here?

Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.

Write It In

Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.

Nature Presents Approach to Uncover Regulatory Noncoding Variants in Cancer, More

In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.

Menu

CareDx, Stanford Add Third Patent to IP Lawsuit Against Natera

To read the full story....

Breaking News

Qiagen Reports Preliminary Q2 Revenue Growth of 18 to 19 Percent

Curetis Gains Access to Additional €5 Million Debt Financing for COVID-19 R&D

Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories

OncoDNA to Acquire IntegraGen for €14.5M

FDA Grants EUAs for Enzo Life Sciences, Access Bio, Gene By Gene Coronavirus Tests

Aneuploidy Common in Early-Stage Human Embryos, Single-Cell RNA-Seq Study Reveals

The Scan

NSF's Investigations

OK, So Who Is Here?

Write It In

Nature Presents Approach to Uncover Regulatory Noncoding Variants in Cancer, More

What's Popular?

Guardant Health to Develop Liquid Biopsy Companion Diagnostic for Janssen NSCLC Therapy

FDA Grants EUAs for Enzo Life Sciences, Access Bio, Gene By Gene Coronavirus Tests

Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

Progenity Asks Court to Declare Non-Infringement of Natera Patents

GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests

Sponsorships